Mutant B2M status (vs wt B2M) increased the log odds of peritoneal/peritoneal and lymphatic metastasis (vs non-peritoneal/peritoneal and lymphatic metastasis) by 3.873 (p=0.00968). Here, B2M is linked to Lymphatic Metastasis.